These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Using animal models to develop therapeutics for Tourette Syndrome. Swerdlow NR; Sutherland AN Pharmacol Ther; 2005 Dec; 108(3):281-93. PubMed ID: 15970330 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological animal models of Tourette syndrome. Bronfeld M; Israelashvili M; Bar-Gad I Neurosci Biobehav Rev; 2013 Jul; 37(6):1101-19. PubMed ID: 23089155 [TBL] [Abstract][Full Text] [Related]
4. Selective breeding for deficient sensorimotor gating is accompanied by increased perseveration in rats. Freudenberg F; Dieckmann M; Winter S; Koch M; Schwabe K Neuroscience; 2007 Sep; 148(3):612-22. PubMed ID: 17693035 [TBL] [Abstract][Full Text] [Related]
5. Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome. Steeves TD; Fox SH Prog Brain Res; 2008; 172():495-513. PubMed ID: 18772048 [TBL] [Abstract][Full Text] [Related]
6. Update: studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome. Swerdlow NR Neurosci Biobehav Rev; 2013 Jul; 37(6):1150-6. PubMed ID: 23017868 [TBL] [Abstract][Full Text] [Related]
8. Establishment of a battery of simple models for facets of bipolar disorder: a practical approach to achieve increased validity, better screening and possible insights into endophenotypes of disease. Einat H Behav Genet; 2007 Jan; 37(1):244-55. PubMed ID: 16865528 [TBL] [Abstract][Full Text] [Related]
10. The D1CT-7 mouse model of Tourette syndrome displays sensorimotor gating deficits in response to spatial confinement. Godar SC; Mosher LJ; Strathman HJ; Gochi AM; Jones CM; Fowler SC; Bortolato M Br J Pharmacol; 2016 Jul; 173(13):2111-21. PubMed ID: 26171666 [TBL] [Abstract][Full Text] [Related]
11. The Wernicke-Kleist-Leonhard "short-circuiting": a missing link between attention deficit hyperactivity disorder, Tourette syndrome, and obsessive-compulsive disorder? Fontenelle LF; Mendlowicz MV Med Hypotheses; 2008 Sep; 71(3):418-25. PubMed ID: 18511213 [TBL] [Abstract][Full Text] [Related]
12. Sensory gating scales and premonitory urges in Tourette syndrome. Sutherland Owens AN; Miguel EC; Swerdlow NR ScientificWorldJournal; 2011 Mar; 11():736-41. PubMed ID: 21442151 [TBL] [Abstract][Full Text] [Related]
13. The relationship between tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical review. Erenberg G Semin Pediatr Neurol; 2005 Dec; 12(4):217-21. PubMed ID: 16780292 [TBL] [Abstract][Full Text] [Related]
14. Pathophysiology of tics and Tourette syndrome. Berardelli A; Currà A; Fabbrini G; Gilio F; Manfredi M J Neurol; 2003 Jul; 250(7):781-7. PubMed ID: 12883917 [TBL] [Abstract][Full Text] [Related]
15. Attention-deficit/hyperactivity disorder, Tourette's syndrome, and restless legs syndrome: the iron hypothesis. Cortese S; Lecendreux M; Bernardina BD; Mouren MC; Sbarbati A; Konofal E Med Hypotheses; 2008; 70(6):1128-32. PubMed ID: 18164140 [TBL] [Abstract][Full Text] [Related]
16. Factors influencing diagnosis delay in children with Tourette syndrome. Shilon Y; Pollak Y; Benarroch F; Gross-Tsur V Eur J Paediatr Neurol; 2008 Sep; 12(5):398-400. PubMed ID: 18055232 [TBL] [Abstract][Full Text] [Related]
17. Animal models with construct validity for schizophrenia. Ellenbroek BA; Cools AR Behav Pharmacol; 1990; 1(6):469-490. PubMed ID: 11175433 [TBL] [Abstract][Full Text] [Related]
18. Transplantation of rat neural stem cells reduces stereotypic behaviors in rats after intrastriatal microinfusion of Tourette syndrome sera. Liu X; Wang Y; Li D; Ju X Behav Brain Res; 2008 Jan; 186(1):84-90. PubMed ID: 17850895 [TBL] [Abstract][Full Text] [Related]
19. Enhanced cognitive control in young people with Tourette's syndrome. Mueller SC; Jackson GM; Dhalla R; Datsopoulos S; Hollis CP Curr Biol; 2006 Mar; 16(6):570-3. PubMed ID: 16546080 [TBL] [Abstract][Full Text] [Related]